Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

High-Throughput, Sensitive LC-MS Quantification of Biotherapeutics and Biomarkers Using Antibody-Free, Peptide-Level, Multiple-Mechanism Enrichment via Strategic Regulation of pH and Ionic and Solvent Strengths.

An B, Zhang M, Pu J, Shen S, Qu Y, Chen YJ, Huo S, Wang X, Polli JR, Balthasar JP, Herzog D, Ferrari L, Staack RF, Richter WF, Otteneder MB, Benincosa LJ, Zhou S, Vazvaei F, Qu J.

Anal Chem. 2019 Mar 5;91(5):3475-3483. doi: 10.1021/acs.analchem.8b05046. Epub 2019 Feb 15.

PMID:
30712341
2.

Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR.

Morris ME, Yang X, Gandhi YA, Bhansali SG, Benincosa LJ.

Biopharm Drug Dispos. 2012 Jan;33(1):1-14. doi: 10.1002/bdd.1761. Epub 2012 Jan 24.

PMID:
22170504
3.

Model-based drug development.

Lalonde RL, Kowalski KG, Hutmacher MM, Ewy W, Nichols DJ, Milligan PA, Corrigan BW, Lockwood PA, Marshall SA, Benincosa LJ, Tensfeldt TG, Parivar K, Amantea M, Glue P, Koide H, Miller R.

Clin Pharmacol Ther. 2007 Jul;82(1):21-32. Epub 2007 May 23. Review.

PMID:
17522597
4.

Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.

Chandra R, Liu P, Breen JD, Fisher J, Xie C, LaBadie R, Benner RJ, Benincosa LJ, Sharma A.

Clin Pharmacokinet. 2007;46(3):247-59.

PMID:
17328583
5.

Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.

Taylor TJ, Diringer K, Russell T, Venkatakrishnan K, Wilner K, Crownover PH, Benincosa LJ, Gibbs MA.

Clin Pharmacokinet. 2006;45(10):989-1001.

PMID:
16984212
6.

Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humans.

Chow FS, Benincosa LJ, Sheth SB, Wilson D, Davis CB, Minthorn EA, Jusko WJ.

Clin Pharmacol Ther. 2002 Apr;71(4):235-45.

PMID:
11956506
7.

An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers.

Zussman BD, Benincosa LJ, Webber DM, Clark DJ, Cowley H, Kelly J, Murdoch RD, Upward J, Wyld P, Port A, Fuder H.

J Clin Pharmacol. 2001 Sep;41(9):950-8.

PMID:
11549099
8.

Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys.

Benincosa LJ, Chow FS, Tobia LP, Kwok DC, Davis CB, Jusko WJ.

J Pharmacol Exp Ther. 2000 Feb;292(2):810-6.

PMID:
10640322
9.

Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.

Zia-Amirhosseini P, Minthorn E, Benincosa LJ, Hart TK, Hottenstein CS, Tobia LA, Davis CB.

J Pharmacol Exp Ther. 1999 Dec;291(3):1060-7.

PMID:
10565825
10.

Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban.

Tran JQ, Di Cicco RA, Sheth SB, Tucci M, Peng L, Jorkasky DK, Hursting MJ, Benincosa LJ.

J Clin Pharmacol. 1999 May;39(5):513-9.

PMID:
10234600
11.

Ibuprofen-induced changes in sulfate renal transport.

Sagawa K, Benincosa LJ, Murer H, Morris ME.

J Pharmacol Exp Ther. 1998 Dec;287(3):1092-7.

PMID:
9864297
12.

Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men.

Martin DE, Zussman BD, Everitt DE, Benincosa LJ, Etheredge RC, Jorkasky DK.

J Clin Psychopharmacol. 1997 Dec;17(6):451-9.

PMID:
9408807
13.

Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects.

Benincosa LJ, Audet PR, Lundberg D, Zariffa N, Jorkasky DK.

Biopharm Drug Dispos. 1996 Apr;17(3):249-58.

PMID:
8983399
14.

Renal adaptation to altered dietary sulfate in rats.

Benincosa LJ, Sagawa K, Morris ME.

J Pharmacol Exp Ther. 1995 Jan;272(1):248-55.

PMID:
7815339
15.

Effects of acute caffeine ingestion and menopause on sulfate homeostasis in women.

Benincosa LJ, Sagawa K, Massey LK, Morris ME.

Life Sci. 1995;57(16):1497-505.

PMID:
7564894
16.

Tiaprofenic acid inhibits the renal reabsorption of sulfate in rats.

Benincosa LJ, Morris ME.

Prostaglandins Leukot Essent Fatty Acids. 1993 Jul;49(1):503-8.

PMID:
8361986
17.

Inhibition of sulfate transport in rat kidney membrane vesicle preparations by nonsteroidal antiinflammatory drugs.

Benincosa LJ, Morris ME.

Drug Metab Dispos. 1993 Jul-Aug;21(4):750-2. No abstract available.

PMID:
8104138
18.

Nonlinear pharmacokinetics and protein binding of tiaprofenic acid in female Lewis rats.

Benincosa LJ, Morris ME.

J Pharm Sci. 1993 Apr;82(4):429-30. No abstract available.

PMID:
8468689
19.

Influence of dibutyryl-cAMP on ibuprofen-induced alterations of sulfate renal clearance in rats.

Benincosa LJ, Morris ME.

Drug Metab Dispos. 1992 May-Jun;20(3):461-4. No abstract available.

PMID:
1355724
20.

Influence of NSAID-induced inhibition of renal prostaglandin synthesis on inorganic sulfate clearance in rats.

Morris ME, Benincosa LJ.

Proc Soc Exp Biol Med. 1992 Apr;199(4):410-6.

PMID:
1549620
21.

Supplemental Content

Loading ...
Support Center